A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2014

Primary Completion Date

August 18, 2014

Study Completion Date

July 3, 2015

Conditions

Infra-orbital Skin Depressions

Interventions

DEVICE

VOLBELLA® with lidocaine

VOLBELLA® with lidocaine administered to correct skin depression during initial treatment and optional top-up treatment 14 days later.

Trial Locations (1)

Lyon